Literature DB >> 15935344

Expression of alphasmooth muscle actin in lens epithelia from human donors and cataract patients.

Elisabeth Rungger-Brändle1, Alain Conti, Peter M Leuenberger, Duri Rungger.   

Abstract

In order to re-evaluate functional implications of alphasmooth muscle actin (alphaSMA) expression in lens epithelial cells (LECs), we assessed its presence in donor lenses without visible opacities (DON), lenses with mature cataract (CAT), and cataractous lenses with posterior subcapsular opacities (PSO) or anterior subcapsular fibrosis (ASF). The levels of alphaSMA and transforming growth factor-beta2 (TGFbeta2) mRNAs were measured by classical and real-time PCR. Expression and structural organisation of alphaSMA protein and beta-catenin were monitored by Western blotting and confocal microscopy. All DON analysed contained measurable amounts of alphaSMA mRNA. In CAT without and with PSO, mRNA expression was increased and, again more than doubled in ASF. TGFbeta2 mRNA expression varied widely between the individual samples but was slightly increased in ASF. No correlation existed between alphaSMA or TGFbeta2 expression and the age of the donors in any of the lens categories. Confocal microscopy revealed that, in DON and CAT, alphaSMA was preferentially expressed in a simple granular pattern in single or small clusters of LECs within a normally shaped cobblestone epithelium. Locally, the granules were merged into short stretches at the cell margin. In CAT, a few abnormally shaped cells contained polygonal alphaSMA structures and short stress fibres. In CAT with PSO and ASF, polygons and stress fibre bundles predominated in spindle-shaped cells. Expression patterns of different complexity were often present in the same epithelium. Apical polygons and basal stress fibres were detected within the same cell and may reflect instability of the interface between epithelium and cortical fibres and changes in adhesion to the capsule, respectively. High levels of betacatenin mRNA and protein were present in all lens types. However, with increasing complexity of alphaSMA organisation, betacatenin staining disappeared from the cell margin and basal infoldings and was shifted towards the cytoplasm and nucleus. The presence of alphaSMA in DON, the absence of any correlation between mRNA level and age, and the modest increase in complexity of alphaSMA-containing structures in CAT argue against an inevitable link between alphaSMA expression and the development of age-related cataract. Low levels of alphaSMA expression may reflect repair of normal wear and tear. In pathologic situations such as PSO and ASF, persisting stimulation and additional incentives may induce increased alphaSMA expression and more elaborate patterning, eventually leading to completion of EMT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15935344     DOI: 10.1016/j.exer.2005.03.012

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  12 in total

1.  alpha-Smooth muscle actin is constitutively expressed in the lens epithelial cells of several species.

Authors:  Claudia M Garcia; Gina P Kwon; David C Beebe
Journal:  Exp Eye Res       Date:  2006-06-12       Impact factor: 3.467

2.  AP-2α is required after lens vesicle formation to maintain lens integrity.

Authors:  Christine L Kerr; Mizna A Zaveri; Michael L Robinson; Trevor Williams; Judith A West-Mays
Journal:  Dev Dyn       Date:  2014-04-30       Impact factor: 3.780

3.  Tropomyosin 2 heterozygous knockout in mice using CRISPR-Cas9 system displays the inhibition of injury-induced epithelial-mesenchymal transition, and lens opacity.

Authors:  Teppei Shibata; Shinsuke Shibata; Yasuhito Ishigaki; Etsuko Kiyokawa; Masahito Ikawa; Dhirendra P Singh; Hiroshi Sasaki; Eri Kubo
Journal:  Mech Ageing Dev       Date:  2018-03-03       Impact factor: 5.432

4.  Association of histone acetylation at the ACTA2 promoter region with epithelial mesenchymal transition of lens epithelial cells.

Authors:  D A Ganatra; S Rajkumar; A R Patel; D U Gajjar; K Johar; A I Arora; F B Kayastha; A R Vasavada
Journal:  Eye (Lond)       Date:  2015-03-20       Impact factor: 3.775

5.  Effects of transforming growth factor β2 and connective tissue growth factor on induction of epithelial mesenchymal transition and extracellular matrix synthesis in human lens epithelial cells.

Authors:  Cheng Pei; Bo Ma; Qian-Yan Kang; Li Qin; Li-Jun Cui
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

6.  Protein expression profiling of lens epithelial cells from Prdx6-depleted mice and their vulnerability to UV radiation exposure.

Authors:  Eri Kubo; Nailia Hasanova; Yukie Tanaka; Nigar Fatma; Yoshihiro Takamura; Dhirendra P Singh; Yoshio Akagi
Journal:  Am J Physiol Cell Physiol       Date:  2009-11-04       Impact factor: 4.249

7.  Cx43, ZO-1, alpha-catenin and beta-catenin in cataractous lens epithelial cells.

Authors:  Anshul I Arora; Kaid Johar; Devarshi U Gajjar; Darshini A Ganatra; Forum B Kayastha; Anuradha K Pal; Alpesh R Patel; S Rajkumar; Abhay R Vasavada
Journal:  J Biosci       Date:  2012-12       Impact factor: 1.826

8.  Expression of transcription factors Slug in the lens epithelial cells undergoing epithelial-mesenchymal transition induced by connective tissue growth factor.

Authors:  Ying-Na Wang; Li Qin; Jing-Ming Li; Li Chen; Cheng Pei
Journal:  Int J Ophthalmol       Date:  2015-10-18       Impact factor: 1.779

9.  Quantitative relationships between transforming growth factor beta mRNA isoforms in congenital and traumatic cataracts.

Authors:  Pawel Banasiak; Barbara Strzalka-Mrozik; Maria Forminska-Kapuscik; Erita Filipek; Urszula Mazurek; Lidia Nawrocka; Ewa Pieczara; Piotr Berezowski; Malgorzata Kimsa
Journal:  Mol Vis       Date:  2011-11-18       Impact factor: 2.367

10.  Elevated tropomyosin expression is associated with epithelial-mesenchymal transition of lens epithelial cells.

Authors:  Eri Kubo; Nailia Hasanova; Nigar Fatma; Hiroshi Sasaki; Dhirendra P Singh
Journal:  J Cell Mol Med       Date:  2012-12-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.